Showing 1 - 17 results of 17 for search '"Neuro-oncology"', query time: 0.07s Refine Results
  1. 1
    Targeting CSF1R Alone or in Combination with PD1 in Experimental Glioma

    Targeting CSF1R Alone or in Combination with PD1 in Experimental Glioma by Justyna M. Przystal, Hannes Becker, Denis Canjuga, Foteini Tsiami, Nicole Anderle, Anna-Lena Keller, Anja Pohl, Carola H. Ries, Martina Schmittnaegel, Nataliya Korinetska, Marilin Koch, Jens Schittenhelm, Marcos Tatagiba, Christian Schmees, Susanne C. Beck, Ghazaleh Tabatabai

    Published 2021-05-01
    Get full text
    Article
  2. 2
    Multiparametric Longitudinal Profiling of RCAS-tva-Induced PDGFB-Driven Experimental Glioma

    Multiparametric Longitudinal Profiling of RCAS-tva-Induced PDGFB-Driven Experimental Glioma by Hannes Becker, Salvador Castaneda-Vega, Kristin Patzwaldt, Justyna M. Przystal, Bianca Walter, Filippo C. Michelotti, Denis Canjuga, Marcos Tatagiba, Bernd Pichler, Susanne C. Beck, Eric C. Holland, Christian la Fougère, Ghazaleh Tabatabai

    Published 2022-10-01
    Get full text
    Article
  3. 3
    Immune Cell Infiltration (Macrophage and Lymphocyte) in Cystic versus Solid Vestibular Schwannoma.

    Immune Cell Infiltration (Macrophage and Lymphocyte) in Cystic versus Solid Vestibular Schwannoma. by Vítor Gonçalves, Rui Vaz, Elisa-Maria Suhm, Vanessa Ries, Marco Skardelly, Ghazaleh Tabatabai, Marcos Tatagiba, Jens Schittenhelm, Felix Behling

    Published 2023-01-01
    Get full text
    Article
  4. 4
    Functionally-instructed modifiers of response to ATR inhibition in experimental glioma

    Functionally-instructed modifiers of response to ATR inhibition in experimental glioma by Bianca Walter, Sophie Hirsch, Laurence Kuhlburger, Aaron Stahl, Leonard Schnabel, Silas Wisser, Lara A. Haeusser, Foteini Tsiami, Sarah Plöger, Narges Aghaallaei, Advaita M Dick, Julia Skokowa, Christian Schmees, Markus Templin, Katja Schenke-Layland, Marcos Tatagiba, Sven Nahnsen, Daniel J. Merk, Ghazaleh Tabatabai

    Published 2024-03-01
    Get full text
    Article
  5. 5
    Glioblastoma: State of the Art and Future Perspectives

    Glioblastoma: State of the Art and Future Perspectives by Ghazaleh Tabatabai, Hiroaki Wakimoto

    Published 2019-07-01
    Get full text
    Article
  6. 6
    Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)

    Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12) by Raphael Bodensohn, Daniel F. Fleischmann, Sebastian H. Maier, Vasiliki Anagnostatou, Sylvia Garny, Alexander Nitschmann, Marcel Büttner, Johannes Mücke, Stephan Schönecker, Kristian Unger, Elgin Hoffmann, Frank Paulsen, Daniela Thorwarth, Adrien Holzgreve, Nathalie L. Albert, Stefanie Corradini, Ghazaleh Tabatabai, Claus Belka, Maximilian Niyazi

    Published 2024-03-01
    Get full text
    Article
  7. 7
    638 Characterisation of the immune response to EO2401, a new immunotherapy approach against cancer, plus nivolumab in recurrent glioblastoma: The EOGBM1–18/ROSALIE study

    638 Characterisation of the immune response to EO2401, a new immunotherapy approach against cancer, plus nivolumab in recurrent glioblastoma: The EOGBM1–18/ROSALIE study by Agostina Stradella, Francois Ghiringhelli, Ana Maia, Macarena Gonzalez, Cécile Gouttefangeas, Ulrich Herrlinger, David Reardon, Ahmed Idbaih, Patrick Wen, Ghazaleh Tabatabai, Wolfgang Wick, Mirjam Renovanz, Maria Vieito Villar, Christophe Bonny, Joao Gamelas Magalhaes, Hélène Toussaint, Jean-Michel Paillarse, Marta GilMartin, Iris Mildenberger, Michael C Burger, Alice Hervieu, Mehdi Touat, Antje Wick

    Published 2023-11-01
    Article
  8. 8
    Patient Reported and Clinical Outcomes after High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma

    Patient Reported and Clinical Outcomes after High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Primary Central Nervous System Lymphoma by Sina A. Beer, Stefan Wirths, Wichard Vogel, Ghazaleh Tabatabai, Ulrike Ernemann, David A. Merle, Wolfgang Bethge, Robert Möhle, Claudia Lengerke

    Published 2023-01-01
    Get full text
    Article
  9. 9
    Correction: Gonçalves et al. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort. <i>Cancers</i> 2021, <i>13</i>, 466

    Correction: Gonçalves et al. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort. <i>Ca... by Vítor Moura Gonçalves, Elisa-Maria Suhm, Vanessa Ries, Marco Skardelly, Ghazaleh Tabatabai, Marcos Tatagiba, Jens Schittenhelm, Felix Behling

    Published 2023-01-01
    Get full text
    Article
  10. 10
    AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas

    AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting p... by Lukas Bunse, Anne-Kathleen Rupp, Isabel Poschke, Theresa Bunse, Katharina Lindner, Antje Wick, Jens Blobner, Martin Misch, Ghazaleh Tabatabai, Martin Glas, Oliver Schnell, Jens Gempt, Monika Denk, Guido Reifenberger, Martin Bendszus, Patrick Wuchter, Joachim P Steinbach, Wolfgang Wick, Michael Platten

    Published 2022-05-01
    “…Until disease progression according to immunotherapy response assessment for neuro-oncology (iRANO) criteria, treatment will be administered over a period of maximum 43 weeks (primary treatment phase) followed by facultative maintenance treatment. …”
    Get full text
    Article
  11. 11
    Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort

    Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort by Vítor Moura Gonçalves, Elisa-Maria Suhm, Vanessa Ries, Marco Skardelly, Ghazaleh Tabatabai, Marcos Tatagiba, Jens Schittenhelm, Felix Behling

    Published 2021-01-01
    Get full text
    Article
  12. 12
    ADC-Based Stratification of Molecular Glioma Subtypes Using High b-Value Diffusion-Weighted Imaging

    ADC-Based Stratification of Molecular Glioma Subtypes Using High b-Value Diffusion-Weighted Imaging by Nils C. Nuessle, Felix Behling, Ghazaleh Tabatabai, Salvador Castaneda Vega, Jens Schittenhelm, Ulrike Ernemann, Uwe Klose, Johann-Martin Hempel

    Published 2021-08-01
    Get full text
    Article
  13. 13
    Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma

    Efficacy of systemic temozolomide‐activated phage‐targeted gene therapy in human glioblastoma by Justyna Magdalena Przystal, Sajee Waramit, Md Zahidul Islam Pranjol, Wenqing Yan, Grace Chu, Aitthiphon Chongchai, Gargi Samarth, Nagore Gene Olaciregui, Ghazaleh Tabatabai, Angel Montero Carcaboso, Eric Ofori Aboagye, Keittisak Suwan, Amin Hajitou

    Published 2019-04-01
    Get full text
    Article
  14. 14
    Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

    Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib by James C. H. Yang, Marcia S. Brose, Gilberto Castro, Edward S. Kim, Ulrik N. Lassen, Serge Leyvraz, Alberto Pappo, Fernando López-Ríos, John A. Reeves, Marc Fellous, Frédérique Penault-Llorca, Erin R. Rudzinski, Ghazaleh Tabatabai, Gilles Vassal, Alexander Drilon, Jonathan Trent

    Published 2022-06-01
    Get full text
    Article
  15. 15
    Uncovering transcriptomic landscape alterations of CAN-2409 in in vitro and in vivo glioma models

    Uncovering transcriptomic landscape alterations of CAN-2409 in in vitro and in vivo glioma models by Marilin S. Koch, Mykola Zdioruk, Michal O. Nowicki, Michael S. Hoetker, Zachary T. Herbert, Francesca Barone, Paul P. Tak, E. Antonio Chiocca, Ghazaleh Tabatabai, Sean E. Lawler, Sean E. Lawler

    Published 2023-05-01
    Get full text
    Article
  16. 16
    Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma

    Perturbing DDR signaling enhances cytotoxic effects of local oncolytic virotherapy and modulates the immune environment in glioma by Marilin S. Koch, Mykola Zdioruk, Michal O. Nowicki, Alec M. Griffith, Estuardo Aguilar-Cordova, Laura K. Aguilar, Brian W. Guzik, Francesca Barone, Paul Peter Tak, Katharina Schregel, Michael S. Hoetker, James A. Lederer, E. Antonio Chiocca, Ghazaleh Tabatabai, Sean E. Lawler

    Published 2022-09-01
    Get full text
    Article
  17. 17
    INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas

    INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas by Niklas Grassl, Katharina Sahm, Heike Süße, Isabel Poschke, Lukas Bunse, Theresa Bunse, Tamara Boschert, Iris Mildenberger, Anne-Kathleen Rupp, Max Philipp Ewinger, Lisa-Marie Lanz, Monika Denk, Ghazaleh Tabatabai, Michael W. Ronellenfitsch, Ulrich Herrlinger, Martin Glas, Dietmar Krex, Peter Vajkoczy, Antje Wick, Inga Harting, Felix Sahm, Andreas von Deimling, Martin Bendszus, Wolfgang Wick, Michael Platten

    Published 2023-10-01
    Get full text
    Article

Search Tools: